Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Imunon Inc (NASDAQ: IMNN) closed at $1.43 in the last session, down -11.73% from day before closing price of $1.62. In other words, the price has decreased by -$11.73 from its previous closing price. On the day, 1.5 million shares were traded.
Ratios:
We take a closer look at IMNN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.88. In the meantime, Its Debt-to-Equity ratio is 2.24 whereas as Long-Term Debt/Eq ratio is at 1.36.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 20 ’24 when Braun Donald P bought 25,000 shares for $1.18 per share. The transaction valued at 29,480 led to the insider holds 25,597 shares of the business.
Lindborg Stacy bought 25,000 shares of IMNN for $24,500 on Aug 15 ’24. The President and CEO now owns 264,166 shares after completing the transaction at $0.98 per share. On Aug 15 ’24, another insider, Tardugno Michael H, who serves as the Executive Chairman of Board of the company, bought 25,000 shares for $1.03 each. As a result, the insider paid 25,750 and bolstered with 353,346 shares of the company.
Stock Price History:
Over the past 52 weeks, IMNN has reached a high of $3.65, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is 33.52%, while the 200-Day Moving Average is calculated to be 47.95%.
Shares Statistics:
A total of 17.54M shares are outstanding, with a floating share count of 15.34M. Insiders hold about 12.55% of the company’s shares, while institutions hold 9.08% stake in the company.
Earnings Estimates
The market rating for Imunon Inc (IMNN) is a result of the insights provided by 4.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.13 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.85 and -$1.24 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.75, with 3.0 analysts recommending between -$0.36 and -$1.1.
